Developer of cell therapies for cancer treatment. It offers genetically engineered T cell, NK cell, and other immune cell-based therapies against multiple malignancies which includes solid tumors.
← All startups
Cellinfinity Bio
Series BDeveloper of cell therapies for cancer treatment. It offers genetically engineered T cell, NK cell, and other immune cell-based therapies against multiple malignancies which includes solid tumors.
About
Institutional investors
HHS
Latest coverage
📰 Browse funding news — rounds, valuations, and market moves for founders.
Investor directory
🗂️ Full list of active funds — filter by stage, check size, and geography.